FDA cybersecurity scrutiny is delaying medical device launches

By AI, Created 4:47 PM UTC, May 18, 2026, /AGP/ – Blue Goat Cyber CEO Christian Espinosa says FDA premarket rejections are rising after the agency’s February 2026 cybersecurity guidance, forcing MedTech teams to treat security as a core design issue before launch. Espinosa will discuss the shift at MedTech World North America, which runs May 11-13 in West Palm Beach.

Why it matters: - FDA cybersecurity review has become a launch risk for medical device makers, with rejections rising, timelines slipping and capital waiting for clearer regulatory expectations. - The shift affects companies across surgical robotics, diagnostics, implantables, AI-enabled software, imaging systems and wearables. - MedTech investors, acquirers and health system partners are increasingly weighing cybersecurity readiness in commercialization decisions.

What happened: - Christian Espinosa, founding CEO of Blue Goat Cyber, will speak at MedTech World North America 2026 from May 11-13 at the Hilton West Palm Beach. - Espinosa says the FDA’s finalized cybersecurity guidance, issued in February 2026, has raised the bar for premarket submissions. - Blue Goat Cyber is a title sponsor of the inaugural U.S. edition of the global MedTech summit series. - Espinosa will join a Tuesday, May 12 panel at 9:40 a.m. in the Oceana Ballroom on scaling neuro innovation. - Espinosa will also co-host an invite-only luncheon on Monday, May 11 at 12:00 p.m. focused on FDA, payers and hackers.

The details: - Blue Goat Cyber has supported FDA premarket submissions for surgical robots, breakthrough designation devices, in vitro diagnostics, AI-enabled software as a medical device, implantables, diagnostic imaging systems and wearable health monitors. - The firm says the regulatory bar has risen since the FDA’s September 2023 draft guidance and increased further with the February 2026 final version. - The neuro innovation panel will include Paula Rutledge of Legacy MedSearch, Kip Roberts of Medtronic, Brad Maruca of Deloitte and Edward Ruppel of Ground Effect Ventures. - The luncheon will also include Edwin Lindsay of CS Lifesciences and host Lori Ellis of Open Door Salon. - Blue Goat Cyber is also sponsoring the MedTech World Awards USA on Monday, May 11 and the Evening Networking VIP Reception on Tuesday, May 12 at IL Bellagio Italian Restaurant. - The Blue Goat Cyber team on site will include Christian Espinosa, Melissa Espinosa and Claudio Salvador. - Attendees can discuss FDA premarket submission readiness, penetration testing, threat modeling and postmarket vulnerability management at the booth. - Blue Goat Cyber’s services include 510(k), De Novo and PMA support, penetration testing, threat modeling, SBOM management, postmarket vulnerability monitoring and global regulatory compliance. - The company was founded by Christian Espinosa, who is also a bestselling author, Air Force veteran, white hat hacker and 24-time Ironman triathlete. - Espinosa previously built and sold Alpine Security. - More information is available at Blue Goat Cyber and the full agenda.

Between the lines: - The message is not just about compliance. It is about how cybersecurity has moved earlier in the product-development process and deeper into business strategy. - Blue Goat Cyber’s expanded sponsorship footprint signals that FDA readiness is now a commercial issue, not only a technical one. - The company is positioning cybersecurity as a gatekeeper for financing, partnerships and exits, not just market entry.

What’s next: - Espinosa’s talks at MedTech World North America will test how broadly that message resonates with founders, investors and regulators. - Medical device teams heading into 2026 are likely to face more pressure to build cybersecurity into design, documentation and postmarket monitoring from the start. - The next key signal will be whether FDA review timelines and rejection rates ease as companies adapt to the updated guidance.

The bottom line: - In MedTech, cybersecurity has shifted from a late-stage checkbox to a launch-critical requirement.